Navigation Links
Vestara and MedClean Technologies Announce Co-Marketing Partnership to Expand Innovative Solution for Pharmaceutical Waste Management
Date:9/21/2009

Vestara announced today a co-marketing agreement with MedClean Technologies (OTC:BB: MCLN), a premier provider of innovative technology and services for the onsite treatment of and disposal of regulated medical waste. Both Vestara and MedClean Technologies believe this strategic partnership will further expand operations and better provide the healthcare industry with the most effective, automated solution that addresses pharmaceutical waste management to control increasing costs and facilitate environmental responsibility.

Irvine, CA (PRWEB) September 21, 2009 -- Vestara announced today a co-marketing agreement with MedClean Technologies (OTC:BB: MCLN), a premier provider of innovative technology and services for the onsite treatment of and disposal of regulated medical waste.

Both Vestara and MedClean Technologies believe this strategic partnership will further expand operations and better provide the healthcare industry with the most effective, automated solution that addresses pharmaceutical waste management to control increasing costs and facilitate environmental responsibility.

Vestara's EcoRex® Automated Pharmaceutical Waste Management System utilizes barcode technology already widely used in hospitals to track drug utilization that prevents medication errors and a proprietary, continuously updated database of more than 180,000 National Drug Code (NDC) products, to instantly categorize pharmaceutical waste at time of presentation. By automating the identification and sorting of different types of residual drugs, empty containers, and each hospital's unique admixtures, EcoRex® eliminates the human error and potential cross contamination inherent in manual sorting of pharmaceutical waste to reduce negative impact on the environment. Just as important, relevant data and an audit trail are provided in the form of comprehensive reports for client records.

MedClean® Series Systems enable hospitals and other medical facilities to treat and dispose of their RMW stream and provide HIPAA-compliant destruction of confidential documents in an efficient, compliant, safe and cost-effective manner. MedClean provides a state-of-the-art on-site treatment solution for each end user through its full line of On-Demand Container, Mobile and in-house, fixed systems. MedClean's solutions provide significant advantages for hospital customers compared to other approaches, including lower costs, reduced risk and protection of host communities and the overall environment. A single MedClean Container system can treat 1 million pounds of RMW per year, in addition to handling confidential document destruction, with a smaller footprint required compared to multiple vendors handling different tasks for a hospital.

Working together, Vestara and MedClean bring unique technologies to a common customer base, addressing the toughest waste mitigation issues facing hospitals today.

Please visit booth # 419 at the 2009 ASHES Conference in Reno, NV, September 21-22, 2009, to learn more about the Vestara-MedClean Technologies partnership.

About Vestara
Vestara, headquartered in Irvine, CA, provides proprietary technology to automatically identify, sort, and segregate hazardous and non-hazardous pharmaceutical waste into proper waste streams. Vestara's solutions not only assure clients will be compliant with all federal and state laws, but that they will experience a more efficient health system workforce and true cost savings in managing pharmaceutical waste. Most importantly, clients will play a critical role in preserving our precious environment. To learn more, visit www.vestara.com.

About MedClean Technologies, Inc.
MedClean Technologies, Inc. is a provider of innovative technology and services for the onsite treatment and disposal of regulated medical waste. MedClean's flagship MedClean® Series systems are fully integrated, turnkey technology solutions that enable hospitals and other healthcare providers to safely, efficiently, and cost-effectively convert bio-hazardous regulated medical waste into sterile, unrecognizable material suitable for disposal as municipal solid waste. MedClean was founded in 1997 with corporate headquarters, research and development and distribution facilities located in Bethel, Connecticut. Further, information on MedClean can be found at www.medcleantechnologies.com and in filings with the Securities and Exchange Commission found at www.sec.gov.

# # #

Read the full story at http://www.prweb.com/releases/2009/09/prweb2870584.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. Vestara Announces Agreement with Leading Environmental "Champion for Change" Company Amerinet
2. MedClean Technologies Inc. Announces New Ticker Symbol
3. MedClean Technologies Inc. CEO Publishes Letter to Shareholders
4. MedClean Technologies, Inc. Announces $1 Million Order
5. MedClean Technologies, Inc. Awarded MedAssets Supply Chain Systems Contract
6. MedClean Technologies, Inc. Approved in New Jersey
7. MedClean Technologies Announces Results of Private Exchange Offer
8. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
9. Cardiovascular Technologies to be Highlighted at 5th Annual Cleveland Clinic Medical Innovation Summit, Oct. 1-3
10. VNUS Medical Technologies Announces Resignation of Chief Financial Officer and VP, Finance & Administration
11. Osteotech to Present at First Albany Capitals Regenerative Technologies Conference in New York
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... ... “The Journey: From the Mountains to the Mission Field”: the story of a missionary ... Journey: From the Mountains to the Mission Field” is the creation of published author, ... ages and currently teaches a class of ladies at her church, which she has ...
(Date:10/12/2017)... LA (PRWEB) , ... October 12, 2017 , ... Planet ... in the U.S., announced today its plans to open a flagship location in Covington, ... occupy the former Rooms To Go store next to Office Depot in the Holiday ...
(Date:10/12/2017)... ... 2017 , ... Asante, a nationally recognized health system in ... existing home health joint venture through an agreement, effective October 1, 2017, to ... home health company with Asante, delivering clinically integrated care, for the past eight ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at ... D.C., for the 49th Congress of the International Society of Paediatric Oncology ... the Center for Cancer and Blood Disorders at Children’s National, and Stephen ...
(Date:10/12/2017)... ... October 12, 2017 , ... In ... taxes a year. In some states—like New York, New Jersey, Massachusetts, Texas, Virginia, ... overseas retirement havens have extremely low property-tax rates, which contributes to the relatively ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)... Texas , Oct. 11, 2017  True ... services, has amplified its effort during National Breast ... about hereditary cancer risks. ... of Clinical Oncology calculated that more than 10 ... have inherited mutations in BRCA1 or BRCA2 and have ...
(Date:10/5/2017)... Ill. , Oct. 5, 2017  In ... Association of Oral and Maxillofacial Surgeons (AAOMS) released ... opioids – to be used as a first-line ... pain. Recognizing ... the AAOMS White Paper "Opioid Prescribing: Acute and ...
(Date:10/2/2017)... -- Eli Lilly and Company (NYSE: LLY ) ... of 2017 on Tuesday, October 24, 2017. Lilly will ... the investment community and media to further detail the ... begin at 9 a.m. Eastern time. Investors, media and ... the conference call through a link that will be ...
Breaking Medicine Technology: